
Key global events and impact on the BioPharma Supply Chain: April 2024 Update
This report summarises the key issues impacting prices across a range of categories in the BioPharma industry in April 2024: Biologics contract manufacturing Due to the incoming BIOSECURE Act in the United States, biologics category managers are expected to look